Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

The test stick is swabbed along the upper and lower gum once and placed into the test tube for 20 minutes before reading the results. The Food and Drug Administration (FDA) has expanded the approval ...

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

Dr Temitope Ilori, the Director-General of the National Agency for the Control of AIDS (NACA) said domestic production of HIV commodities such as test kits and anti-retroviral drugs was part of ...

is urging residents to prioritize early HIV testing to ensure long-term health and curb the spread of the virus. HIV cases surge in Pangasinan HIV compromises the immune system by targeting white ...

HIV (Human Immunodeficiency Virus ... an increased incidence of cardiovascular events in the first two years of INSTI exposure, the risk decreased to levels similar to those without INSTI exposure ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps ...

MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapid test has ...